[Musculoskeletal tumor evaluation with 99mTc-Tetrofosmin].

Area of Science:

• Nuclear Medicine
• Oncology
• Musculoskeletal Imaging

Background:

• 99mTc-tetrofosmin is an established tumor marker with high efficacy in various cancers.
• It demonstrates 95-100% sensitivity and specificity for detecting and localizing tumors across multiple tissue types.
• Applications include predicting therapy response and identifying residual or recurrent disease.

Purpose of the Study:

• To evaluate the diagnostic performance of the three-phase 99mTc-tetrofosmin scan.
• Specifically, to determine its sensitivity, specificity, and predictive values for malignant musculoskeletal lesions.

Main Methods:

• A study involving seventy-three patients with suspected malignant musculoskeletal lesions.
• Utilized three-phase 99mTc-tetrofosmin scintigraphy: vascular, tissue, and delayed imaging.

Main Results:

• Achieved 100% sensitivity in detecting malignant musculoskeletal lesions.
• Reported 67.3% specificity, 55% positive predictive value, and 100% negative predictive value.
• High sensitivity indicates strong capability in identifying true positives.

Conclusions:

• The three-phase 99mTc-tetrofosmin scan is a valuable tool for detecting musculoskeletal malignancies due to its high sensitivity.
• High positive predictive value supports its utility, but false positives from benign conditions like inflammation require consideration.
• Complementary diagnostic methods, such as histopathology, are recommended for definitive diagnosis.